
zzso a zzso zzso analogous to the zzso site of zzso zzso is under development by zzso (formerly zzso as a potential subcutaneous treatment for zzso lateral sclerosis zzso stroke, spinal zzso injury, lung inflammation and zzso The compound is currently undergoing a phase I clinical trial for zzso In October 2005, the company had applied for Fast Track status, and planned to submit a special protocol assessment for a pivotal phase zzso zzso 

